ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyAllschwilIdorsia Pharmaceuticals Ltd
Idorsia Pharmaceuticals Ltd Logo
Verified· 4 sourcesTrust Score
Summary

About the company

Idorsia Pharmaceuticals Ltd discovers, develops, and commercializes medicines. Its activities include drug research and clinical development across therapeutic areas such as central nervous system, cardiovascular and immunological disorders, and rare diseases.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.2/5

Idorsia Pharmaceuticals Ltd

✓ Offered3
Discovery, development and marketing of innovative medicines
Discovery, development, registration and marketing of innovative treatments for the target indications insomnia, hypertension and Fabry disease; focus on small molecules and pipeline products.
Compassionate Use Program
Access to investigational medicinal products for qualified physicians for serious or life-threatening diseases, when no approved alternatives or appropriate studies are available.
Transparency and disclosure reports
Publication of transfers of value to healthcare professionals, healthcare organisations and patient organisations in accordance with country-specific rules and industry codes across multiple markets.
Trust & reputation

ranQ Trust Score of Idorsia Pharmaceuticals Ltd: 4.2 out of 5.0

Trust Score4.2/ 5.0

Very high

x

Data basis 100% · As of November 2026

Idorsia Pharmaceuticals Ltd scores 65.9 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.51.924%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.76.210%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.95.08%
Idorsia Pharmaceuticals Ltd scores 89.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.100.07%
Idorsia Pharmaceuticals Ltd scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Idorsia Pharmaceuticals Ltd scores 73.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.46.74%
Qualifications+0.00

Idorsia Pharmaceuticals Ltd reaches a ranQ Trust Score of 4.2 out of 5.0 — rated «Very high». The rating draws, among other things, on 3.9 out of 5 stars from 19 customer reviews. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
3.9
of 5

Aggregated from 19 reviews across all connected sources

Sources
GGoogle3.919
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

July 30, 2026Media
Idorsia kommt voran und findet clevere Lösung
fuw.ch
July 29, 2026Media
Idorsia signs Saudi partner for insomnia drug
startupticker.ch
June 30, 2026Media
Idorsia secures CHF250 million loan
startupticker.ch

Knowledge

No knowledge articles yet

Once Idorsia Pharmaceuticals Ltd has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Idorsia Pharmaceuticals Ltd in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Idorsia Pharmaceuticals Ltd by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Idorsia Pharmaceuticals Ltd to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 91
4123 Allschwil
Opening hours
Mon
07:30 - 16:30
Tue
07:30 - 16:30
Wed
07:30 - 16:30
Thu
07:30 - 16:30
Fri
07:30 - 16:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-232.876.339
Founded
2017 · 9 years
Last commercial register change
November 3, 2026
Employees
More than 500
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    AT
    Alloy Therapeutics (Switzerland) AG
    Allschwil
    GG
    Gubra GmbH
    Allschwil
    PT
    Palto Therapeutics AG
    Allschwil
    NS
    Neurocrine Switzerland GmbH
    Allschwil
    AP
    Actelion Pharmaceuticals Ltd
    Allschwil
    BP
    Basilea Pharmaceutica International AG, Allschwil
    Allschwil
    CA
    Curatis AG
    Liestal
    AH
    Accord Healthcare AG
    Bottmingen